Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: 17.7m AUD

Creso Pharma Ltd
Investor Relations

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Boaz Wachtel M.A., M.D., MBA
Co-Founder & Non-Exec. Chairman
No Bio Available
Mr. Christopher Grundy
Chief Financial Officer
No Bio Available
Mr. William Lay B.Com.
Group CEO, MD & Director
No Bio Available
Dr. Gian Trepp
Commercial & Marketing Director
No Bio Available
Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.
MD & Exec. Director
No Bio Available
Ms. Jodi Scott
Exec. Director & Pres of US Operations
No Bio Available
Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom
Joint Company Sec.
No Bio Available
Dr. Simon H. W. Buckingham
Consultant
No Bio Available
Hon. Brian Walker
Strategic Consultant & Chair of Scientific Advisory Committee
No Bio Available

Contacts

Address
WESTERN AUSTRALIA
Suite 5 CPC, 145 Stirling Highway, Nedlends
Contacts